Chapter 15: Monitoring tuberculosis program performance

References

• World Health Organization. Strategy for the control and elimination of tuberculosis. In: Implementing the WHO Stop TB Strategy: A Handbook for National Tuberculosis Control Programmes. Geneva: WHO Press; 2008.
   Google Scholar
• Cole B, Nilsen DM, Will L, Etkind SC, Burgos M, Chorba T. Essential Components of a Public Health Tuberculosis Prevention, Control, and Elimination Program: Recommendations of the Advisory Council for the Elimination of Tuberculosis and the National Tuberculosis Controllers Association. MMWR Recomm Rep. 2020;69(7):1–27. doi:10.15585/mmwr.rr6907a1.
   PubMed Web of Science ®Google Scholar
• Uplekar M, Weil D, Lonnroth K, et al. WHO’s new End TB Strategy. The Lancet. 2015;385(9979):1799–1801. doi:10.1016/S0140-6736(15)60570-0.
   PubMed Web of Science ®Google Scholar
• World Health Organization. The End TB Strategy. https://www.who.int/tb/strategy/End_TB_Strategy.pdf. Published 2015. Accessed July 5, 2021.
   Google Scholar
• Australian Government Department of Health and Ageing. The strategic plan for control of tuberculosis in Australia: 2011–2015. Australian Government Department of Health and Ageing. www1.health.gov.au. Accessed June 30, 2021.
   Google Scholar
• Degeling C, Carroll J, Denholm J, Marais B, Dawson A. Ending TB in Australia: Organizational challenges for regional tuberculosis programs. Health Policy. 2020;124(1):106–112. doi:10.1016/j.healthpol.2019.11.009.
   PubMed Web of Science ®Google Scholar
• Public Health England. Collaborative TB Strategy for England, 2015 to 2020: end of programme report. 2015. GW-1954.
   Google Scholar
• Pan American Health Organization. The End TB Strategy: Main Indicators in the Americas. 2020.
   Google Scholar
• Kritski A, Barreira D, Junqueira-Kipnis AP, et al. Brazilian Response to Global End TB Strategy: The National Tuberculosis Research Agenda. Revista da Sociedade Brasileira de Medicina Tropical. 2016;49:135–145. doi:10.1590/0037-8682-0330-2015.
   PubMed Web of Science ®Google Scholar
• Davidson EJ. Evaluative Reasoning. Methodological Briefs: Impact Evaluation. 2014;4:1–14.
   Google Scholar
• Coelho AA, Martiniano CS, Brito EWG, et al. Tuberculosis care: an evaluability study. Revista Latino-Americana de Enfermagem. 2014;22(5):792–800. doi:10.1590/0104-1169.3294.2482.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control. Framework for Program Evaluation in Public Health. MMWR. 1999;48(RR-11):1–40.
   PubMedGoogle Scholar
• Health Canada. Health Canada’s Strategy against Tuberculosis for First Nations on-Reserve. Ottawa, Ont.: Health Canada; 2012.
   Google Scholar
• Health Canada. Health Canada’s Monitoring and Performance Framework for Tuberculosis Programs for First Nations on-Reserve. Feb 12 2016.
   Google Scholar
• Pan-Canadian Public Health Network. Guidance for Tuberculosis Prevention and Control Programs in Canada. 2013.
   Google Scholar
• Inuit Tapiriit Kanatami. Inuit Tuberculosis Elimination Framework. 2018.
   Google Scholar
• Haworth-Brockman M, Balakumar S, Head B, Keynan Y. Towards TB Elimination: Shared Priorities for TB Program Performance Measurement in Canada, a Proposal for Discussion. Winnipeg, Manitoba: National Collaborating Centre for Infectious Diseases; June 2019. 453.
   Google Scholar
• Cass A, Shaw T, Ehman M, Young J, Flood J, Royce S. Improved Outcomes Found After Implementing a Systematic Evaluation and Program Improvement Process for Tuberculosis. Public Health Reports. 1974-). 2013;128(5):367–376. doi:10.1177/003335491312800507.
   Google Scholar
• Cavany SM, Sumner T, Vynnycky E, et al. An evaluation of tuberculosis contact investigations against national standards. Thorax. 2017;72(8):736–745. doi:10.1136/thoraxjnl-2016-209677.
   PubMed Web of Science ®Google Scholar
• Government of Canada, Public Health Agency of Canada. Reported cases from 1924 to 2019 in Canada - Notifiable diseases on-line. https://diseases.canada.ca/notifiable/charts?c=pl. Published 2000. Updated Accessed January 1, 2000.
   Google Scholar
• Proceedings of the National Consensus Conference on Tuberculosis. December 3-5, 1997. 1998;24(Supplement 2):1-24.
   Google Scholar
• The global plan to stop TB 2006-2015: actions for life: towards a world free of tuberculosis. Geneva: Stop TB Partnership; 2006.
   Google Scholar
• Stewart TR. The Delphi technique and judgmental forecasting. Clim Change. 1987;11(1-2):97–113. doi:10.1007/BF00138797.
   Google Scholar
• Niederberger M, Spranger J. Delphi Technique in Health Sciences: A Map. Front Public Health. 2020;8:457. doi:10.3389/fpubh.2020.00457.
   PubMed Web of Science ®Google Scholar
• von Schirnding Y. Health in Sustainable Development Planning: The Role of Indicators. Geneva: World Health Organization; 2002. WHO/HDE/HID/02.11.
   Google Scholar
• Langlois-Klassen D, Wooldrage KM, Manfreda J, et al. Piecing the puzzle together: foreign-born tuberculosis in an immigrant-receiving country. European Respiratory Journal. 2011;38(4):895–902. doi:10.1183/09031936.00196610.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global Tuberculosis Control: surveillance, Planning, Financing. Geneva: WHO Press; 2005.
   Google Scholar
• Asadi L, Heffernan C, Menzies D, Long R. Effectiveness of Canada’s tuberculosis surveillance strategy in identifying immigrants at risk of developing and transmitting tuberculosis: a population-based retrospective cohort study. The Lancet Public Health. 2017;2(10):e450–e457. doi:10.1016/S2468-2667(17)30161-5.
   PubMed Web of Science ®Google Scholar
• Greenaway C, Pareek M, Chakra C-NA, et al. The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU/EEA: a systematic review. Eurosurveillance. 2018;23(14):17. doi:10.2807/1560-7917.ES.2018.23.14.17-00543.
   Web of Science ®Google Scholar
• Berrocal-Almanza LC, Harris R, Lalor MK, et al. Effectiveness of pre-entry active tuberculosis and post-entry latent tuberculosis screening in new entrants to the UK: a retrospective, population-based cohort study. The Lancet Infectious Diseases. 2019;19(11):1191–1201. doi:10.1016/S1473-3099(19)30260-9.
   PubMed Web of Science ®Google Scholar
• Kruijshaar ME, Abubakar I, Stagg HR, Pedrazzoli D, Lipman M. Migration and tuberculosis in the UK: targeting screening for latent infection to those at greatest risk of disease. Thorax. 2013;68(12):1172–1174. doi:10.1136/thoraxjnl-2013-203254.
   PubMed Web of Science ®Google Scholar
• Ehman M, Shaw T, Cass A, et al. Developing and Using Performance Measures Based on Surveillance Data for Program Improvement in Tuberculosis Control. Journal of Public Health Management and Practice. 2013;19(5):E29–E37. doi:10.1097/PHH.0b013e3182751d6f.
   PubMed Web of Science ®Google Scholar
• Stop TB Partnership, World Health Organization. The Global Plan to Stob TB 2011-2015: transforming the Fight towards Elimination of Tuberculosis. Geneva: World Health Organization; 2011.
   Google Scholar
• Horsburgh CR, Feldman S, Ridzon R. Practice Guidelines for the Treatment of Tuberculosis. Clinical Infectious Diseases. 2000;31(3):633–639. doi:10.1086/314007.
   PubMed Web of Science ®Google Scholar
• Curtis E, Jones R, Tipene-Leach D, et al. Why cultural safety rather than cultural competency is required to achieve health equity: a literature review and recommended definition. International Journal for Equity in Health. 2019;18(1):174. doi:10.1186/s12939-019-1082-3.
   PubMed Web of Science ®Google Scholar
• Canadian Health Services Research Foundation. Performance Reporting to Help Organizations Promote Quality Improvement. Healthcare Policy | Politiques de Santé. 2008;4(2):70–74.
   Google Scholar
• Health Canada. Health Portfolio Sex and Gender-Based Analysis Policy. https://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/heath-portfolio-sex-gender-based-analysis-policy.html. Published 2017. Accessed July 27, 2021.
   Google Scholar
• World Health Organization. Closing data gaps in gender. https://www.who.int/activities/improving-treatment-for-snakebite-patients. Published 2019. Accessed July 27, 2021.
   Google Scholar
• Global Health Data Exchange | GHDx. http://ghdx.healthdata.org/. Accessed July 27, 2021.
   Google Scholar
• Gigli KH. Data Disaggregation: A Research Tool to Identify Health Inequities. Journal of Pediatric Health Care. 2021;35(3):332–336. doi:10.1016/j.pedhc.2020.12.002.
   PubMed Web of Science ®Google Scholar
• Gomes MGM, Barreto ML, Glaziou P, et al. End TB strategy: the need to reduce risk inequalities. BMC Infectious Diseases. 2016;16(1):132. doi:10.1186/s12879-016-1464-8.
   PubMedGoogle Scholar
• Smith A, Herington E, Loshak H. Tuberculosis Stigma and Racism, Colonialism, and Migration: A Rapid Qualitative Review. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2021.
   Google Scholar
• Mathema B, Andrews JR, Cohen T, et al. Drivers of Tuberculosis Transmission. J Infect Dis. 2017;216(suppl_6):S644–S653. doi:10.1093/infdis/jix354.
   PubMedGoogle Scholar
• Kwan CK, Ernst JD. HIV and Tuberculosis: a Deadly Human Syndemic. Clinical Microbiology Reviews. 2011;24(2):351–376. doi:10.1128/CMR.00042-10.
   PubMed Web of Science ®Google Scholar
• Gupta KB, Gupta R, Atreja A, Verma M, Vishvkarma S. Tuberculosis and nutrition. Lung India: Official Organ of Indian Chest Society. 2009;26(1):9–16. doi:10.4103/0970-2113.45198.
   PubMedGoogle Scholar
• Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. International Journal of Drug Policy. 2007;18(4):306–312. doi:10.1016/j.drugpo.2007.03.001.
   PubMed Web of Science ®Google Scholar
• Zumla A, Malon P, Henderson J, Grange J. Impact of HIV infection on tuberculosis. Postgraduate Medical Journal. 2000;76(895):259–268. doi:10.1136/pmj.76.895.259.
   PubMed Web of Science ®Google Scholar
• Marais BJ, Lönnroth K, Lawn SD, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. The Lancet Infectious Diseases. 2013;13(5):436–448. doi:10.1016/S1473-3099(13)70015-X.
   PubMed Web of Science ®Google Scholar
• Cormier M, Schwartzman K, N’Diaye DS, et al. Proximate determinants of tuberculosis in Indigenous peoples worldwide: a systematic review. The Lancet Global Health. 2019;7(1):e68–e80. doi:10.1016/S2214-109X(18)30435-2.
   PubMed Web of Science ®Google Scholar
• Ali M. Treating tuberculosis as a social disease. The Lancet. 2014;383(9936):2195. doi:10.1016/S0140-6736(14)61063-1.
   PubMed Web of Science ®Google Scholar
• Khan K, Rea E, McDermaid C, et al. Active Tuberculosis among Homeless Persons, Toronto, Ontario, Canada, 1998–2007. Emerging Infectious Diseases. 2011;17(3):357–365. doi:10.3201/eid1703.100833.
   PubMed Web of Science ®Google Scholar
• Marks SM, Taylor Z, Burrows NR, Qayad MG, Miller B. Hospitalization of homeless persons with tuberculosis in the United States. Am. J. Public Health. 2000;90(3):435–438. doi:10.2105/ajph.90.3.435.
   PubMed Web of Science ®Google Scholar
• Parriott A, Malekinejad M, Miller AP, Marks SM, Horvath H, Kahn JG. Care Cascade for targeted tuberculosis testing and linkage to Care in Homeless Populations in the United States: a meta-analysis. BMC Public Health. 2018;18:485. doi:10.1186/s12889-018-5393-x.
   PubMed Web of Science ®Google Scholar
• Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: A systematic review. BMC Medicine. 2011;9(1):81. doi:10.1186/1741-7015-9-81.
   PubMed Web of Science ®Google Scholar
• Stevenson CR, Forouhi NG, Roglic G, et al. Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health. 2007;7(1):234. doi:10.1186/1471-2458-7-234.
   PubMedGoogle Scholar
• World Health Organization. Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs. Geneva: World Health Organization; 2004.
   Google Scholar
• Henderson DA. The challenge of eradication: lessons from past eradication campaigns. Int J Tuberc Lung Dis. 1998;2(9 Suppl 1): S4–S8.
   Web of Science ®Google Scholar
• World Health Organization. International Health Regulations. Geneva: WHO Press; 2005.
   Google Scholar
• Center for Disease Control. TB - National TB Program Objectives and Performance Targets for 2025. Centers for Disease Control and Prevention Web site. https://www.cdc.gov/tb/programs/evaluation/indicators/default.htm. Published 2019. Accessed September 18, 2019.
   Google Scholar
• Bareja C, Waring J, Stapledon R, Toms C, Douglas P. Tuberculosis notifications in Australia. Commun Dis Intell. 2011;38(4):E356–E368. 2014;
   Google Scholar
• Alaska Departement of Health and Social Services. Alaska Tuberculosis Program Manual. 2017.
   Google Scholar
• Minnesota Department of Health. Published 2021. https://www.health.state.mn.us/diseases/tb/stats/index.html. Accessed Jul 6, 2021.
   Google Scholar
• California Department of Public Health. TB Performance Trends for National and California Objectives. 2016.
   Google Scholar
• Heffernan C, Long R. Would program performance indicators and a nationally coordinated response accelerate the elimination of tuberculosis in Canada? Can J Public Health. 2019;110(1):31–35. doi:10.17269/s41997-018-0106-x.
   PubMed Web of Science ®Google Scholar
• Chan IHY, Kaushik N, Dobler CC. Post-migration follow-up of migrants identified to be at increased risk of developing tuberculosis at pre-migration screening: a systematic review and meta-analysis. The Lancet Infectious Diseases. 2017;17(7):770–779. doi:10.1016/S1473-3099(17)30194-9.
   PubMed Web of Science ®Google Scholar
• Long R, Asadi L, Heffernan C, et al. Is there a fundamental flaw in Canada’s post-arrival immigrant surveillance system for tuberculosis? PLOS One. 2019;14(3):e0212706. doi:10.1371/journal.pone.0212706.
   PubMed Web of Science ®Google Scholar
• Ronald LA, Campbell JR, Rose C, et al. Estimated impact of World Health Organization latent tuberculosis screening guidelines in a region with a low tuberculosis incidence: retrospective cohort study. Clin Infect Dis. 2019;69(12):2101–2108. doi:10.1093/cid/ciz188.
   PubMed Web of Science ®Google Scholar
• Long R, Ellis E. Public Health Agency of Canada, Canadian Lung Association, Canadian Thoracic Society. Canadian Tuberculosis Standards. 2007.
   Google Scholar
• Rutstein SE, Ananworanich J, Fidler S, et al. Clinical and public health implications of acute and early HIV detection and treatment: a scoping review. J Int AIDS Soc. 2017;20(1):21579. doi:10.7448/IAS.20.1.21579.
   PubMed Web of Science ®Google Scholar
• Long R, Niruban S, Heffernan C, et al. A 10-year population based study of ‘opt-out’ HIV testing of tuberculosis patients in Alberta, Canada: national implications. PLoS One. 2014;9(6):e98993. doi:10.1371/journal.pone.0098993.
   PubMed Web of Science ®Google Scholar
• Bogers SJ, Hulstein SH, Schim van der Loeff MF, et al. Current evidence on the adoption of indicator condition guided testing for HIV in western countries: A systematic review and meta-analysis. EClinicalMedicine. 2021;35:100877. doi:10.1016/j.eclinm.2021.100877.
   PubMedGoogle Scholar
• World Health Organization, UNAIDS, The Global Fund, PEPFAR. A Guide to Monitoring and Evaluation for Collaborative TB/HIV Activities-2015 Revisions. Geneva: WHO Press; 2015.
   Google Scholar
• Canadian Medical Association. Guidelines for the identification, investigation and treatment of individuals with concomitant tuberculosis and HIV infection. Bureau of Communicable Disease Epidemiology, Canada Department of National Health and Welfare. CMAJ. 1993;148(11):1963–1970.
   Web of Science ®Google Scholar
• Long R, Houston S, Hershfield E. Canadian Tuberculosis Committee of the Centre for Infectious Disease P, Control P, Public Health Branch HC. Recommendations for screening and prevention of tuberculosis in patients with HIV and for screening for HIV in patients with tuberculosis and their contacts. CMAJ. 2003;169(8):789–791.
   PubMed Web of Science ®Google Scholar
• Haworth-Brockman MJ, Keynan Y. Strengthening tuberculosis surveillance in Canada. CMAJ. 2019;191(26):E743–E744. doi:10.1503/cmaj.72225.
   PubMed Web of Science ®Google Scholar
• Migliori GB, Nardell E, Yedilbayev A, et al. Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe. Eur Respir J. 2019;53(6):1900391. doi:10.1183/13993003.00391-2019.
   PubMed Web of Science ®Google Scholar
• Golub JE, Bur S, Cronin WA, et al. Delayed tuberculosis diagnosis and tuberculosis transmission. The International Journal of Tuberculosis and Lung Disease. 2006;10(1):24–30.
   PubMed Web of Science ®Google Scholar
• Mitchison DA. Infectivity of patients with pulmonary tuberculosis during chemotherapy. Eur Respir J. 1990;3(4):385–386.
   Web of Science ®Google Scholar
• LaFreniere M, Dam D, Strudwick L, McDermott S. Tuberculosis drug resistance in Canada: 2018. Can Commun Dis Rep. 2020;46(1):9–15. doi:10.14745/ccdr.v46i01a02.
   PubMedGoogle Scholar
• Benator D, Bhattacharya M, Bozeman L, et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet (London, England). 2002;360(9332):528–534.
   PubMed Web of Science ®Google Scholar
• Calderwood CJ, Wilson JP, Fielding KL, et al. Dynamics of sputum conversion during effective tuberculosis treatment: A systematic review and meta-analysis. PLOS Med. 2021;18(4):e1003566. doi:10.1371/journal.pmed.1003566.
   PubMed Web of Science ®Google Scholar
• World Health Organization. WHA44.8 TUBERCULOSIS CONTROL PROGRAMME. 1991.
   Google Scholar
• Hargreaves JR, Boccia D, Evans CA, Adato M, Petticrew M, Porter JDH. The Social Determinants of Tuberculosis: From Evidence to Action. Am. J. Public Health. 2011;101(4):654–662. doi:10.2105/AJPH.2010.199505.
   PubMed Web of Science ®Google Scholar
• Veen J. Microepidemics of tuberculosis: the stone-in-the-pond principle. Tuber Lung Dis. 1992;73(2):73–76. doi:10.1016/0962-8479(92)90058-R.
   PubMedGoogle Scholar
• Fox GJ, Dobler CC, Marks GB. Active case finding in contacts of people with tuberculosis. The Cochrane Database of Systematic Reviews. 2011;(9):CD008477. doi:10.1002/14651858.CD008477.pub2.
   PubMed Web of Science ®Google Scholar
• National Tuberculosis Controllers A, Centers for Disease C, Prevention. Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. MMWR Recomm Rep. 2005;54(RR-15):1–47.
   Google Scholar
• Luzzati R, Migliori GB, Zignol M, et al. Children under 5 years are at risk for tuberculosis after occasional contact with highly contagious patients: outbreak from a smear-positive healthcare worker. Eur Respir J. 2017;50(5):1701414. doi:10.1183/13993003.01414-2017.
   PubMed Web of Science ®Google Scholar
• Daley CL, Small PM, Schecter GF, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. The New England Journal of Medicine. 1992;326(4):231–235. doi:10.1056/NEJM199201233260404.
   PubMed Web of Science ®Google Scholar
• Canada PHAo. Chapter 12: Canadian Tuberculosis Standards 7th Edition: 2014 – Contact follow-up and outbreak management in Tuberculosis control. Published 2014. https://www.canada.ca/en/public-health/services/infectious-diseases/canadian-tuberculosis-standards-7th-edition/edition-8.html. Accessed February 17, 2014.
   Google Scholar
• Ai J-W, Ruan Q-L, Liu Q-H, Zhang W-H. Updates on the risk factors for latent tuberculosis reactivation and their managements. Emerging Microbes Infect. 2016;5(2):e10. doi:10.1038/emi.2016.10.
   PubMedGoogle Scholar
• Fox GJ, Dobler CC, Marais BJ, Denholm JT. Preventive therapy for latent tuberculosis infection—the promise and the challenges. International Journal of Infectious Diseases. 2017;56:68–76. doi:10.1016/j.ijid.2016.11.006.
   PubMed Web of Science ®Google Scholar
• Rangaka MX, Cavalcante SC, Marais BJ, et al. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet. 2015;386(10010):2344–2353. doi:10.1016/S0140-6736(15)00323-2.
   PubMed Web of Science ®Google Scholar
• Dobler CC, Martin A, Marks GB. Benefit of treatment of latent tuberculosis infection in individual patients. European Respiratory Journal. 2015;46(5):1397–1406. doi:10.1183/13993003.00577-2015.
   PubMed Web of Science ®Google Scholar
• Kim HW, Kim JS. Treatment of Latent Tuberculosis Infection and Its Clinical Efficacy. Tuberculosis and Respiratory Diseases. 2018;81(1):6–12. doi:10.4046/trd.2017.0052.
   PubMed Web of Science ®Google Scholar
• Comstock GW, Edwards PQ. The competing risks of tuberculosis and hepatitis for adult tuberculin reactors. Am Rev Respir Dis. 1975;111(5):573–577. doi:10.1164/arrd.1975.111.5.573.
   PubMedGoogle Scholar
• Menzies D, Adjobimey M, Ruslami R, et al. Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults. N Engl J Med. 2018;379(5):440–453. doi:10.1056/NEJMoa1714283.
   PubMed Web of Science ®Google Scholar
• Macaraig MM, Jalees M, Lam C, Burzynski J. Improved treatment completion with shorter treatment regimens for latent tuberculous infection. Int j Tuberc Lung Dis. 2018;22(11):1344–1349. doi:10.5588/ijtld.18.0035.
   PubMed Web of Science ®Google Scholar
• Ferebee SH, Mount FW. Tuberculosis Morbidity in a Controlled Trial of the Prophylactic Use of Isoniazid among Household Contacts. American Review of Respiratory Disease. 1962;85(4):490–510.
   PubMedGoogle Scholar
• Molhave M, Wejse C. Historical review of studies on the effect of treating latent tuberculosis. Int J Infect Dis. 2020;92S:S31–S36. doi:10.1016/j.ijid.2020.03.011.
   PubMedGoogle Scholar